Indoco Remedies Overview
- Year Founded
-
1945
- Status
-
Public
- Employees
-
5,744
- Stock Symbol
-
532612
- Investments
-
6
- Share Price
-
$2.43
- (As of Friday Closing)
Indoco Remedies General Information
Description
Indoco Remedies Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The company has only one business segment i.e Pharmaceutical Products. The company generates majority of revenue from India.
Contact Information
Website
www.indoco.comCorporate Office
- Indoco House
- 166 CST Road, Santacruz (East)
- Mumbai, Maharashtra 400098
- India
Corporate Office
- Indoco House
- 166 CST Road, Santacruz (East)
- Mumbai, Maharashtra 400098
- India
Indoco Remedies Stock Performance
As of 13-Nov-2026, Indoco Remedies’s stock price is $2.43. Its current market cap is $224M with 92.2M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.43 | $2.44 | $1.73 - $3.05 | $224M | 92.2M | 38.9K | $0.04 |
Indoco Remedies Financials Summary
As of 30-Sep-2026, Indoco Remedies has a trailing 12-month revenue of $201M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 362,235 | 262,643 | 343,157 | 412,872 |
| Revenue | 200,971 | 202,905 | 194,104 | 216,005 |
| EBITDA | 32,986 | 10,348 | 11,904 | 31,242 |
| Net Income | 3,446 | (10,766) | (8,720) | 11,893 |
| Total Assets | 272,015 | 274,849 | 284,070 | 257,182 |
| Total Debt | 110,273 | 115,497 | 116,153 | 80,576 |
Indoco Remedies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Indoco Remedies Patents
Indoco Remedies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250073162-A1 | A stable injectable composition of triamcinolone acetonide | Pending | 17-Mar-2022 | ||
| WO-2023175420-A1 | A stable injectable composition of triamcinolone acetonide | Inactive | 17-Mar-2022 | ||
| WO-2022195382-A1 | A stable ophthalmic nanosupension of brinzolamide | Inactive | 19-Mar-2021 | ||
| WO-2022023822-A1 | A stable ophthalmic composition of posaconazole | Inactive | 30-Jul-2020 | ||
| WO-2019073481-A1 | Process for the preparation of brexpiprazole and its intermediates | Inactive | 12-Oct-2017 | C07D409/12 |
Indoco Remedies Signals
Indoco Remedies Investments & Acquisitions (6)
Indoco Remedies’s most recent deal was a Merger/Acquisition with Florida Pharmaceutical Products for . The deal was made on 06-Jun-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Florida Pharmaceutical Products | 06-Jun-2023 | Merger/Acquisition | Pharmaceuticals | ||
| Jalansar Wind Energy | 30-Sep-2022 | Secondary Transaction - Private | Special Purpose Acquisition Company (SPAC) | ||
| Micro Labs (Pharmaceutical Plant Baddi) | 21-Sep-2016 | Corporate Asset Purchase | Buildings and Property | ||
| Piramal (clinical research division) | 06-Apr-2015 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| La Nova Chem | 04-Jul-2006 | Merger/Acquisition | Pharmaceuticals |
Indoco Remedies ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.87 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Indoco Remedies Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Florida Pharmaceutical Products | Boca Raton, FL | 1999 |
Indoco Remedies FAQs
-
When was Indoco Remedies founded?
Indoco Remedies was founded in 1945.
-
Where is Indoco Remedies headquartered?
Indoco Remedies is headquartered in Mumbai, India.
-
What is the size of Indoco Remedies?
Indoco Remedies has 5,744 total employees.
-
What industry is Indoco Remedies in?
Indoco Remedies’s primary industry is Drug Discovery.
-
Is Indoco Remedies a private or public company?
Indoco Remedies is a Public company.
-
What is Indoco Remedies’s stock symbol?
The ticker symbol for Indoco Remedies is 532612.
-
What is the current stock price of Indoco Remedies?
As of 13-Nov-2026 the stock price of Indoco Remedies is $2.43.
-
What is the current market cap of Indoco Remedies?
The current market capitalization of Indoco Remedies is $224M.
-
What is Indoco Remedies’s current revenue?
The trailing twelve month revenue for Indoco Remedies is $201M.
-
What is Indoco Remedies’s annual earnings per share (EPS)?
Indoco Remedies’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process